share_log

Xeris Pharmaceuticals Q2 EPS $(0.19) Up From $(0.41) YoY, Sales $25.31M Miss $25.53M Estimate

Benzinga Real-time News ·  Aug 10, 2022 07:10

Xeris Pharmaceuticals (NASDAQ:XERS) reported quarterly losses of $(0.19) per share. This is a 53.66 percent increase over losses of $(0.41) per share from the same period last year. The company reported quarterly sales of $25.31 million which missed the analyst consensus estimate of $25.53 million by 0.88 percent. This is a 186.43 percent increase over sales of $8.84 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment